GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Genome & Co (XKRX:314130) » Definitions » Cash Flow from Others

Genome (XKRX:314130) Cash Flow from Others : ₩5,001 Mil (TTM As of Sep. 2024)


View and export this data going back to 2018. Start your Free Trial

What is Genome Cash Flow from Others?

Genome's cash flow from others for the three months ended in Sep. 2024 was ₩713 Mil. Its cash flow from others for the trailing twelve months (TTM) ended in Sep. 2024 was ₩5,001 Mil.


Genome Cash Flow from Others Historical Data

The historical data trend for Genome's Cash Flow from Others can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Genome Cash Flow from Others Chart

Genome Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cash Flow from Others
Get a 7-Day Free Trial 70,891.45 5,138.08 241.99 2,316.66 2,096.26

Genome Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Cash Flow from Others Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 634.10 4,752.08 441.36 -905.05 712.77

Genome Cash Flow from Others Calculation

Cash Flow from Others for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩5,001 Mil.

Genome Cash Flow from Others Related Terms

Thank you for viewing the detailed overview of Genome's Cash Flow from Others provided by GuruFocus.com. Please click on the following links to see related term pages.


Genome Business Description

Traded in Other Exchanges
N/A
Address
Innovalley A-801, Pangyo-ro 253, Bundang-gu, Gyeonggi-do, Seongnam-si, KOR, 13486
Genome & Co is a Korean company engaged in researching and developing dietary supplements, cosmeceuticals, and new drugs. Its products pipeline includes immunooncology therapeutic supplement for treatment of immuno-oncology, lung cancer, colorectal cancer, stomach cancer, breast cancer, pancreatic cancer; dietary supplements for treating obesity and diabetes; cosmetics used for acne and atopic dermatitis; and also produces In Virto fertilization medicine.

Genome Headlines

No Headlines